Physician profile
Ethan E Payne
NPI 1598024093
$1,860.85
in general payments reported to CMS, 2019-2025
22 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $164 · 2021: $93.33 · 2022: $324 · 2023: $363 · 2024: $448 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $831.48 | 2019-2025 | Clareon, Rocklatan, Rhopressa |
| Abbvie INC. | $170.57 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $136.04 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $106.80 | 2022 | |
| Rxsight INC | $81.99 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Allergan, INC. | $65.35 | 2020-2021 | |
| Ocular Therapeutix, INC. | $60.00 | 2022-2024 | Dextenza |
| Sight Sciences, INC. | $57.01 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $40.70 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Omeros Corporation | $37.18 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $31.24 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $30.58 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $29.44 | 2019-2020 | |
| Iridex Corporation | $28.88 | 2019 | |
| Bausch & Lomb Americas INC. | $28.36 | 2023-2025 | Miebo, Vyzulta, Xiidra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $23.87 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Shire North American Group INC | $19.28 | 2019 | |
| Horizon Therapeutics Plc | $17.99 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.03 | 2021 | |
| Eyevance Pharmaceuticals LLC | $14.39 | 2020 | |
| Tearlab Corp | $13.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.